Recrutier.com Group Inc has launched a comprehensive content series exploring the powerful impact of the artificial intelligence technology ChatGPT on talent acquisition and recruiting.
The company said the series consists of three resources designed to help organizations leverage the power of ChatGPT to streamline their recruitment processes and find the best talent on the market.
Atlantic Lithium has received a share price target upgrade from Liberum after the upgrade to the resource at its Ewoyaa deposit in Ghana.
Liberum has raised its target to 57p based on a new preliminary 3Mtpa DFS case (from 46p).
Casa Minerals Inc (TSX-V:CASA, OTC:CASXF) has announced assay results of the initial exploration at its Congress Gold Mine Project in Arizona, which included 14.9 grams per tonne (g/t) gold over 1.5 meters (m) as part of a larger intercept of 3.5 g/t over 10.7m.
The explorer and mineral properties developer said results of the field program exceeded expectations, with all the drill holes intersecting the Niagara and Congress Veins extensions on the property and yielded several noteworthy gold intercepts and long intervals of strong gold enrichment.
Avricore Health (TSX-V:AVCR, OTC:AVCRF) Inc said it has successfully entered the second year of a multi-year growth plan to bring its flagship HealthTab network, a turnkey point-of-care data management and testing solution, to more pharmacies.
In a corporate update, the Vancouver, British Columbia-based pharmacy service innovator provided insights into its achievements last year and spelt out its key objectives for 2023.
RespireRx Pharmaceuticals (OTC:RSPI) Inc announced that its recently created Australia-based subsidiary ResolutionRx Ltd has signed a letter of intent (LOI) and term sheet with Radium Capital.
The agreements cover a series of planned financing arrangements between the two companies designed to unlock research and development tax credits available in Australia, the company said. Radium, founded in 2017, is in the business of funding secured loans to Australian companies engaged in research and development activities.
Versus Systems Inc. (NASDAQ:VS, CSE:VS) has announced that it will partner with automated debt collection and artificial intelligence (AI) company Resolve Debt Inc. to bring gamification and interactive elements to Resolve’s existing AI-powered credit and debt management products and customers.
The company said the goal of the partnership is to address a portion of the $4.5 trillion US consumer (non-mortgage) debt market.
Electric Royalties Ltd (TSX-V:ELEC, OTC:ELECF) has provided an asset update on nine royalties in its current portfolio, which the company says sets the stage for an “exciting” year for Electric Royalties’ shareholders.
“With the recent acquisition of a royalty on the Penouta tin-tantalum mine, our second cash-flowing royalty, we are eager for the Authier lithium project to enter production – planned for later this year – which has the potential to become our first lithium cash-flowing royalty,” Electric Royalties CEO Brendan Yurik said in a statement.
Reunion Gold Corporation (TSX-V:RGD, OTCQB:RGDFF) has announced drill results from its Oko West property in central Guyana that, once again, expand the known mineralization at the Block 4 zone, broker Stifel GMP said in a note as it kept its ‘Buy’ rating and C$0.60 price target on the stock.
Analysts at the US brokerage noted that assay highlights include 11.04 grams per tonne (g/t) over 40 metres (m), 1.32 g/t over 121m, and 0.93 g/t over 61m.
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) announced that it has received approval from Health Canada for its experiential training study that will test the safety and clinical efficacy of whole Psilocybe cubensis tea for therapeutic use, and enable practitioners to further their understanding of psychedelic-assisted therapy through experiential training.
The clinical trial, formally titled ‘A Phase 1, Open-Label, Single-Arm Study to Evaluate Psilocybin Experiential Training in Healthy Volunteers and Expand Knowledge and Qualifications of Therapists Planning to Conduct Psilocybin-Assisted Therapy (NUMT2)’, will initially be conducted at Numinus’ clinic in Vancouver, and will begin selecting volunteers in the next several weeks, the company said.
Reunion Gold Corporation (TSX-V:RGD, OTCQB:RGDFF) has announced results from an additional 38 holes drilled on its Oko West project in Guyana, South America, including 39.5 metres (m) at 11.04 grams per tonne (g/t) gold.
The company said the drilling, which totalled 14,965m included additional diamond drilling within the Block 4 zone, extending the known extent of mineralization down dip and along strike, while also demonstrating the potential for higher grade, structurally controlled shoots within the broader mineralized system.
Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) has provided an update on its operations and said it has set its 2023 capital budget at a total of US$32 million.
The company said the contracted 1,500 HP drilling rig has arrived at the multiwell pad at Rio Cravo Este (RCE).
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) said it has appointed advisers to prepare for a potential dual listing of the company’s shares on the Saudi Exchange, based in Riyadh, in the Kingdom of Saudi Arabia.
The Saudi Exchange is currently the 11th largest stock exchange in the world, with 223 listed companies, with a combined market capitalisation of US$2.63 trillion as of 31 December 2022. The total value of shares traded on the Saudi Exchange in 2022 was US$455bn and the ‘Materials Industry’ group was the largest sector on the market by value of trades, representing 23.8% of the overall market. There were 22 IPOs on the Saudi Exchange in 2022.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), the developer of novel immunotherapies for the treatment of cancer and infectious disease, has announced the appointment of Dr Jean-Michel Cosséry as its non-executive chairman with immediate effect.
The company said Cosséry will seek to drive Scancell’s strategy for clinical progress and commercial development of its novel immunotherapy vaccine and antibody platforms, noting that he brings to the company over 25 years of experience in the pharmaceutical and biotechnology industries and a sustained global track record of success in commercial operations as well as in capital raising, US and European public offerings, business development and M&A.
Argo Blockchain PLC (LSE:ARB, OTCQX:ARBKF, NASDAQ:ARBK, ETR:0XP) has announced the resignation of chief financial officer (CFO) and executive director Alex Appleton following the successful sale of Argo’s Texas-based Helios facility to Galaxy Digital (TSX-V:GLXY) Holdings on 29 December 2022.
Appleton, who is departing to pursue other opportunities, commented: “I am very proud of what we have achieved over my time with Argo. The business has great potential, and I wish the Argo team all the best for the future.”
Keywords Studios PLC (AIM:KWS, OTC:KYYWF) has acquired US-based PR and communications agency 47 Communications for an undisclosed sum.
The UK group, which provides support services for the video games industry, said the deal would boost its marketing and PR offering in the US.
Lake Resources NL (ASX:LKE, OTCQB:LLKKF) has strengthened its human resources capabilities with the appointment of Gentry Brann as the company’s first chief people and administration officer.
Brann will lead the company’s human resources functions as well as advance diversity and inclusion as the lithium development company expands.
Race Oncology Ltd (ASX:RAC) has received human ethics approval from the Hunter New England Human Research Ethics Committee (NSW, Australia) for the initial observational stage of a planned interventional Phase 1/2b cardioprotection clinical program using Zantrene® (bisantrene dihydrochloride).
This observation trial is the first step in advancing the cardioprotection opportunity for Zantrene in the clinic.
Western Magnesium Corp. (TSX-V:WMG, OTCQB:MLYF) said it has closed the final tranche of its non-brokered private placement previously announced on November 16, 2022. The final tranche closed on 903,545 units for gross proceeds of US$74,413, making total gross proceeds raised of US$1.3 million. Each unit in the placement consists of one common share in the capital of Western Magnesium and one common share purchase warrant. Each warrant will be exercisable into one common share for a period of two years at a price of 18 US cents per share. The closing of the final tranche is subject to final approval by the TSX Venture Exchange. The completion of the private placement and payment of any commission and fees remains subject to the receipt of all necessary approvals, including the approval of the TSX Venture Exchange. The securities issued will be subject to a statutory hold period in Canada for a period of four months and one day from the closing date.
Marble Financial Inc. (CSE:MRBL, OTC:MRBLF) said it has issued 150,000 stock options under the company’s stock option plans to two employees. These options expire five years from the date of grant, vest in equal one-fourth amounts starting on the date of grant and in each of the first-year, second-year and third-year anniversaries from the date of grant, and are exercisable at 8 cents per share. The grant of the stock options is subject to approval from the Canadian Securities Exchange.
Silver Bullet Mines Corp. (TSX-V:SBMI, OTC:SBMCF) said the TSX Venture Exchange has consented to the extension of the expiry date of 8,528,081 warrants with an original expiry date of between February 6, 2023, and July 8, 2023, to a new expiry date of warrants between February 6, 2024, and July 8, 2024, at an unchanged exercise price 50 cents each. These warrants were issued under a private placement of 17,056,150 shares with 8,528,081 share purchase warrants attached completed in different tranches prior to the completion of the company’s qualifying transaction on December 1, 2021.
Psyched Wellness Ltd (CSE:PSYC, OTCQB:PSYCF) has said it will be launching a new larger bottle size for their proprietary Amanita Muscaria Extract (AME-1) product Calm, on February 28, 2023. The new size will provide customers with double the servings per bottle, in a 60ml package. Calm is the first legal Amanita Muscaria extract available for sale in the USA. Jeffrey Stevens, Psyched Wellness CEO, commented: “We’ve been getting a lot of feedback from our customers about how much they love our product and find it helpful, so we’ve decided to give them what they want: more of it. The new 60ml size is the perfect compromise between convenience and potency: it provides more servings per bottle while still allowing users to get the same amount of AME-1 as they would with the 30ml bottle. This launch comes as we prepare the ground for an exciting year ahead-full of new products and formats.”
Burcon NutraScience Corp (TSX:BU) will hold an investor conference call and webcast on Tuesday, February 14, 2023 at 5:00 p.m. ET to discuss its financial results for the fiscal third quarter ended December 31, 2022. The company’s financial results will be issued in a press release prior to the call. A link to the webcast of the conference call will be available on Burcon’s website under “Presentations” or directly here: Investors interested in participating in the live call can dial in using the following details: Toll-free dial-in (North America): 1-855-327-6837; Dial-in (toll/international): 1-631-891-4304; Conference ID: 10021125.
KULR Technology Group Inc (NYSE:KULR) announced that it has retained Integrous Communications as its investor relations advisor. Integrous Communications will assist KULR with communicating its corporate, financial and investor developments to current shareholders and prospective investors, while enhancing awareness of the company’s story within the capital markets. Mark Komonoski, Partner at Integrous Communications, will be the Company’s primary investor contact. “We are committed to growing our investor reach and implementing best practices in our corporate communications,” stated Michael Mo, CEO of KULR. “On the basis of their decades of experience assisting companies like KULR, we have selected Integrous Communications as our investor relations advisor. Their depth of relationships and sector expertise provides us with the best-in-class support to communicate our corporate and operational progress to existing and new shareholders.”
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) said that as a result of delays to its audit, the company’s annual financial statements and accompanying management’s discussion and analysis for the fiscal year ended October 31, 2022 were not finalized by January 30, 2023, being the date that such filings are due under applicable Canadian securities law requirements. The company has applied for, and has been granted, a management cease trade order by the British Columbia Securities Commission. The reason for the delay relates to the change in accounting firms and the considerable work involved in the transition of accountants, particularly due to the complex nature of Wellbeing’s business. Wellbeing is working diligently with its auditors and financial professionals to complete the audit in a timely manner. The company currently expects to file the Annual Filings on or before March 31, 2023, and will issue a news release announcing completion of such filings at such time.